Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Conjugated Estrogen Cream for Atrophic Vaginitis
NCT00137371Phase 3Completed
- Sponsor
- Pfizer
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of conjugated estrogens in atrophic vaginitis (4 arms), sponsored by Pfizer. Primary endpoints: Change from baseline in percentage of superficial cells at 12 weeks, Change from baseline in vaginal pH at 12 weeks and 1 more. Started Aug 2005; status: completed.
02
Drugs
conjugated estrogens
03
Conditions
atrophic vaginitis
Beyond the preview
Go deeper on NCT00137371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00137371.